ImmuCell Corporation

NasdaqCM ICCC

ImmuCell Corporation Share Price on February 06, 2025: USD 5.36

ImmuCell Corporation Share Price is USD 5.36 on February 06, 2025, a 4.08% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.
  • ImmuCell Corporation 52-week high Share Price is USD 5.50 on January 17, 2025, which is 2.61% above the current Share Price.
  • ImmuCell Corporation 52-week low Share Price is USD 3.53 on November 13, 2024, which is -34.14% below the current Share Price.
  • ImmuCell Corporation average Share Price for the last 52 weeks is USD 4.46.
Key data
Date Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B)
Market news
Loading...
SV Wall Street
NasdaqCM: ICCC

ImmuCell Corporation

CEO Mr. Michael F. Brigham
IPO Date May 5, 1987
Location United States
Headquarters 56 Evergreen Drive
Employees 75
Sector Consumers Staples
Industries
Description

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.

Similar companies

MNOV

MediciNova, Inc.

USD 1.92

0.52%

LIPO

Lipella Pharmaceuticals Inc.

USD 4.65

80.23%

RZLT

Rezolute, Inc.

USD 5.12

-8.08%

CVKD

Cadrenal Therapeutics, Inc. Common Stock

USD 19.10

-3.29%

FENC

Fennec Pharmaceuticals Inc.

USD 6.66

-1.92%

ANEB

Anebulo Pharmaceuticals, Inc.

USD 1.54

-1.91%

StockViz Staff

February 7, 2025

Any question? Send us an email